Clinical Trial Update: Human Umbilical Cord-derived Mesenchymal Stem Cells With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating human umbilical cord-derived mesenchymal stem cells with injectable collagen scaffold for chronic ischemic cardiomyopathy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cardiomyopathy

Drugs mentioned

• Human Umbilical Cord-derived Mesenchymal Stem Cells with Injectable Collagen Scaffold (mesenchymal stem cells with injectable collagen scaffold)

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: Chronic Ischemic Cardiomyopathy | Phase 1, Phase 2 | Status: COMPLETED